Amoxicillin Dosing for Pediatric Bacterial Sinusitis
For a 107 lb (48.5 kg) pediatric patient with bacterial sinusitis, the recommended dose of amoxicillin is 45-90 mg/kg/day divided in two doses, which equals approximately 1100-2200 mg twice daily. 1
Dosing Algorithm
Step 1: Assess Risk Factors for Resistant Organisms
- Determine if the patient has any of the following:
- Age younger than 2 years
- Attendance at childcare
- Antimicrobial treatment within the previous 30 days
- Moderate to severe illness
Step 2: Select Appropriate Dosing Based on Risk Factors
For Uncomplicated Cases (No Risk Factors):
- Standard-dose amoxicillin: 45 mg/kg/day in 2 divided doses
- For 48.5 kg patient = approximately 1100 mg twice daily
For Complicated Cases (With Risk Factors):
- High-dose amoxicillin: 80-90 mg/kg/day in 2 divided doses
- For 48.5 kg patient = approximately 1940-2200 mg twice daily
- Maximum: 2 g per dose 1
Step 3: Consider Alternative Regimens if Needed
If beta-lactamase producing organisms are suspected or the patient has failed standard amoxicillin therapy:
- High-dose amoxicillin-clavulanate: 90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day of clavulanate in 2 divided doses 1
Important Clinical Considerations
Local Resistance Patterns: In communities with high prevalence (>10%) of nonsusceptible S. pneumoniae, use high-dose amoxicillin even for uncomplicated cases 1
Duration of Therapy:
Monitoring Response:
- Assess for clinical improvement within 72 hours of starting treatment
- If no improvement is observed, consider changing to an alternative antibiotic 1
Penicillin Allergy:
Common Pitfalls to Avoid
Underdosing: Using adult standard doses (500 mg twice daily) rather than weight-based dosing can lead to treatment failure, especially with resistant organisms 1
Overdiagnosis: Ensure the diagnosis is truly bacterial sinusitis rather than viral upper respiratory infection to avoid unnecessary antibiotic use 1
Failure to Adjust for Risk Factors: Not using high-dose regimens when risk factors for resistant organisms are present 1
Inappropriate Duration: Stopping therapy too soon after symptom resolution can lead to relapse 1
The evidence strongly supports using appropriate weight-based dosing of amoxicillin as first-line therapy for pediatric bacterial sinusitis, with dose adjustments based on risk factors for resistant organisms. This approach optimizes clinical outcomes while minimizing the risk of treatment failure and complications.